Atrium Therapeutics, Inc.

RNA chart

Atrium Therapeutics, Inc. news

• What Atrium Therapeutics' New ATR-1072 Data Could Mean for PRKAG2 Heart Disease Research(NASDAQ:RNA)

  Kalkine · Nov 3, 4:29 AM EST

• Atrium Therapeutics to Present Nonclinical Data Showing ATR 1072 Reversed and Improved Features of PRKAG2 Syndrome During HCMS at AHA Scientific Sessions 2026

  Yahoo Finance · Nov 2, 6:30 AM EST

• Atrium Therapeutics Doses First Patient in Corventis™, the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome

  Yahoo Finance · Oct 27, 6:30 AM EDT

• Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  Yahoo Finance · Oct 20, 5:23 PM EDT

• Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing

  Yahoo Finance · Oct 20, 8:09 AM EDT

• Atrium Therapeutics Announces $50 Million Private Placement

  Yahoo Finance · Oct 8, 6:30 AM EDT

• Wall Street Money Is Leaving Just As Atrium’s (RNA) Pipeline Turns Real

  Yahoo Finance · Sep 6, 6:44 AM EDT

• Atrium Therapeutics to Participate in Upcoming Investor Conferences

  Yahoo Finance · Sep 2, 8:00 AM EDT

• Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?

  Yahoo Finance · Aug 28, 3:42 PM EDT

• Atrium Therapeutics Reports Second Quarter 2026 Financial Results

  Yahoo Finance · Aug 13, 4:44 PM EDT

• Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

  Yahoo Finance · Aug 13, 8:00 AM EDT

• Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls

  Yahoo Finance · Aug 6, 9:48 AM EDT

Atrium Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-02
• 8-K8-K2026-10-27
• 8-K/A8-K/A2026-10-09
• 8-K8-K2026-10-08
• 10-Q10-Q2026-08-13
• 8-K8-K2026-08-13
• 8-K8-K2026-07-14
• 10-Q10-Q2026-05-14
• 8-K8-K2026-05-14
• 8-K8-K2026-02-27
• 8-K8-K2026-02-26

About Atrium Therapeutics, Inc.

Ticker

RNA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Diego, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2093101

Frequently asked questions